Zhongwei Liu

10PUBLICATIONS
23CO-AUTHORS
Medical biochemistry - lipidsPredictive and prognostic markersMedical devicesMolecular targetsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 04, 2026
Liraglutide reprograms vascular smooth muscle cell metabolism to suppress extracellular matrix remodeling in diabetic atherosclerosis.

|Jun 23, 2026
Mex-3 RNA-binding family member A limits macrophage ferroptosis-associated injury linked to the SLC7A11/GPX4 pathway in diabetic atherosclerosis.

|Mar 28, 2026
Mitophagy in Macrophages: A Metabolic Checkpoint in Inflammation-to-Repair Transition in Atherosclerosis.

Jie Zhou, Hanxiu Liu, Sen Ma

|Oct 11, 2024
Therapeutic Suppression of Atherosclerotic Burden and Vulnerability via Dll4 Inhibition in Plaque Macrophages Using Dual-Targeted Liposomes.

Haixia Du, Yanpeng Ma, Xiqiang Wang

|Sep 20, 2024
Epigenetic modification of CD4+ T cells into Tregs by 5-azacytidine as cellular therapeutic for atherosclerosis treatment.

Ling Zhu, Zhongwei Liu, Qianwei Cui

|Feb 12, 2024
Palmitic acid in type 2 diabetes mellitus promotes atherosclerotic plaque vulnerability via macrophage Dll4 signaling.

Xiqiang Wang, Ling Zhu, Jing Liu

Pageof 2

Frequent Collaborators

2 joint publications

Yujie Xing

2 joint publications

Ling Zhu

2 joint publications

Junkui Wang

2 joint publications

Shuo Pan